TransMedics Group, Inc. (TMDX)
NASDAQ: TMDX · Real-Time Price · USD
73.59
-1.18 (-1.58%)
At close: Jun 11, 2026, 4:00 PM EDT
73.86
+0.27 (0.37%)
Pre-market: Jun 12, 2026, 8:36 AM EDT
TransMedics Group Market Cap
TransMedics Group has a market cap or net worth of $2.54 billion as of June 12, 2026. Its market cap has decreased by -41.56% in one year.
Market Cap
2.54B
Enterprise Value
2.95B
1-Year Change
-41.56%
Ranking
Category
Stock Price
$73.59
Market Cap Chart
Since May 2, 2019, TransMedics Group's market cap has increased from $452.48M to $2.54B, an increase of 462.09%. That is a compound annual growth rate of 27.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 11, 2026 | 2.54B | -38.82% |
| Dec 31, 2025 | 4.16B | 98.67% |
| Dec 31, 2024 | 2.09B | -18.79% |
| Dec 29, 2023 | 2.58B | 30.78% |
| Dec 30, 2022 | 1.97B | 270.34% |
| Dec 31, 2021 | 532.04M | -1.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 2, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| LivaNova | 4.31B |
| iRhythm Holdings | 3.75B |
| Haemonetics | 3.58B |
| Integer Holdings | 3.10B |
| Establishment Labs Holdings | 2.34B |
| Axogen | 2.20B |
| Neogen | 2.00B |
| NovoCure | 1.93B |